Implantica AG Statistics
Total Valuation
Implantica AG has a market cap or net worth of 1.47 billion. The enterprise value is 1.40 billion.
| Market Cap | 1.47B |
| Enterprise Value | 1.40B |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 8.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 629.05 |
| PB Ratio | 14.02 |
| P/TBV Ratio | 21.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -60.26 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -71.16 |
Financial Position
The company has a current ratio of 23.98, with a Debt / Equity ratio of 0.00.
| Current Ratio | 23.98 |
| Quick Ratio | 23.86 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -28.80 |
Financial Efficiency
Return on equity (ROE) is -20.39% and return on invested capital (ROIC) is -12.91%.
| Return on Equity (ROE) | -20.39% |
| Return on Assets (ROA) | -12.52% |
| Return on Invested Capital (ROIC) | -12.91% |
| Return on Capital Employed (ROCE) | -22.69% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 46,580 |
| Profits Per Employee | -463,311 |
| Employee Count | 50 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 13.22 |
Taxes
In the past 12 months, Implantica AG has paid 55,145 in taxes.
| Income Tax | 55,145 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 561 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Implantica AG had revenue of 2.33 million and -23.17 million in losses. Loss per share was -0.08.
| Revenue | 2.33M |
| Gross Profit | -1.23M |
| Operating Income | -23.82M |
| Pretax Income | -23.37M |
| Net Income | -23.17M |
| EBITDA | -23.80M |
| EBIT | -23.82M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 62.51 million in cash and 124,369 in debt, with a net cash position of 62.39 million.
| Cash & Cash Equivalents | 62.51M |
| Total Debt | 124,369 |
| Net Cash | 62.39M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 104.53M |
| Book Value Per Share | 0.38 |
| Working Capital | 63.17M |
Cash Flow
In the last 12 months, operating cash flow was -19.53 million and capital expenditures -85,651, giving a free cash flow of -19.62 million.
| Operating Cash Flow | -19.53M |
| Capital Expenditures | -85,651 |
| Free Cash Flow | -19.62M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -52.90% |
| Operating Margin | -1,022.87% |
| Pretax Margin | -1,003.48% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Implantica AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | -1.58% |
| FCF Yield | -1.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Implantica AG has an Altman Z-Score of 240.48 and a Piotroski F-Score of 3.
| Altman Z-Score | 240.48 |
| Piotroski F-Score | 3 |